4/A: CalciMedica Officer Amends Filing to Disclose Omitted Stock Purchase
SEC Filing
Eric W. Roberts, Chief Business Officer of CalciMedica, amends a previous SEC Form 4 filing to include the purchase of 3,000 shares of common stock held in his Roth IRA.
Summary
- Eric W. Roberts, Chief Business Officer of CalciMedica, filed an amendment to a previous Form 4.
- The amendment corrects an omission in the original filing regarding a purchase of CalciMedica common stock.
- The omitted transaction involved the purchase of 3,000 shares of common stock by Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA on May 17, 2023.
- The shares were purchased at a price of $2.68 per share.
- Following the purchase, Roberts indirectly owned 3,000 shares of common stock held by the Oppenheimer IRA.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing correcting a previous omission. It doesn't inherently convey positive or negative sentiment.
Industry Context
This is a routine disclosure of insider trading activity, required by the SEC to ensure transparency and prevent illegal insider trading.
Stakeholder Impact
- The amendment provides shareholders with a more accurate view of the beneficial ownership of CalciMedica's shares.
Key Dates
| Date | Description |
|---|---|
| 05/16/2023 | Date of Earliest Transaction |
| 05/17/2023 | Date of Common Stock Purchase |
| 05/18/2023 | Date of Original Filed Form 4 |
| 11/06/2024 | Date of Signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.